1Correa P (1988) A human model of gastric carcinogenesis. Cancer Res 48, 3554–3560.
2Uemura N, Okamoto S, Yamamoto S, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345, 784–789.
3Sasazuki S, Inoue M, Sawada N, et al. (2010) Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case–control study: Japan Public Health Center-based prospective study. Carcinogenesis 31, 712–718.
4Libby P (2002) Inflammation in atherosclerosis. Nature 420, 868–874.
5Ilhan N, Ilhan Y, Akbulut H, et al. (2004) C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 10, 1115–1120.
6Maury CP (1985) Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci (Lond) 68, 233–238.
7Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, et al. (1998) Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 7, 449–454.
8Zhang ZW & Farthing MJ (2005) The roles of vitamin C in Helicobacter pylori associated gastric carcinogenesis. Chin J Dig Dis 6, 53–58.
9Jenab M, Riboli E, Ferrari P, et al. (2006) Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 27, 2250–2257.
10Tsubono Y, Okubo S, Hayashi M, et al. (1997) A randomized controlled trial for chemoprevention of gastric cancer in high-risk Japanese population; study design, feasibility and protocol modification. Jpn J Cancer Res 88, 344–349.
11Tsugane S, Tsubono Y, Okubo S, et al. (1996) A pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population: study design and feasibility evaluation. Jpn J Cancer Res 87, 676–679.
12Omenn GS, Goodman GE, Thornquist MD, et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88, 1550–1559.
14Miki K (1998) Pepsinogen Method. Tokyo: Igakushoin.
15Miki K (1997) Basic evaluation of pepsinogen EIA kit. Jpn J Med Pharm Sci 37, 1013–1021.
16Watanabe Y, Kurata JH, Mizuno S, et al. (1997) Helicobacter pylori infection and gastric cancer. A nested case–control study in a rural area of Japan. Dig Dis Sci 42, 1383–1387.
17Kim MK, Sasazuki S, Sasaki S, et al. (2003) Effect of five-year supplementation of vitamin C on serum vitamin C concentration and consumption of vegetables and fruits in middle-aged Japanese: a randomized controlled trial. J Am Coll Nutr 22, 208–216.
18Council for Science and Technology & Ministry of Education, Science and Technology, Japan (2005) Standard Tables of Food Composition in Japan, the Fifth Revised and Enlarged Edition. Tokyo: National Printing Bureau.
19Sasazuki S, Sasaki S, Tsubono Y, et al. (2003) The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection. Cancer Sci 94, 378–382.
20Park SH, Jeon WK, Kim SH, et al. (2005) Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc 97, 508–513.
21Kubota Y, Moriyama Y, Yamagishi K, et al. (2010) Serum vitamin C concentration and hs-CRP level in middle-aged Japanese men and women. Atherosclerosis 208, 496–500.
22Cao L, Xu J, Lin Y, et al. (2009) Autophagy is upregulated in rats with status epilepticus and partly inhibited by vitamin E. Biochem Biophys Res Commun 379, 949–953.
23Mera R, Fontham ET, Bravo LE, et al. (2005) Long term follow up of patients treated for Helicobacter pylori infection. Gut 54, 1536–1540.
24Greenberg ER, Baron JA, Tosteson TD, et al. (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331, 141–147.
25Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52, 6735–6740.
26Fock KM, Talley N, Moayyedi P, et al. (2008) Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 23, 351–365.
27Kebapcilar L, Bilgir O, Cetinkaya E, et al. (2010) The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels. Clinics (Sao Paulo) 65, 799–802.
28Block G, Jensen C, Dietrich M, et al. (2004) Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 23, 141–147.
29Pancorbo D, Vazquez C & Fletcher MA (2008) Vitamin C-lipid metabolites: uptake and retention and effect on plasma C-reactive protein and oxidized LDL levels in healthy volunteers. Med Sci Monit 14, CR547–CR551.
30Eshmuratov A, Nah JC, Kim N, et al. (2010) The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci 55, 1364–1375.
31Sasazuki S, Hayashi T, Nakachi K, et al. (2008) Protective effect of vitamin C on oxidative stress: a randomized controlled trial. Int J Vitam Nutr Res 78, 121–128.
32Sasaki S, Tsubono Y, Okubo S, et al. (2000) Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population. Jpn J Cancer Res 91, 464–470.
33Huang HY, Appel LJ, Croft KD, et al. (2002) Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 76, 549–555.
34Kim MK, Sasaki S, Sasazuki S, et al. (2004) Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects. Br J Nutr 91, 81–90.
35Castell JV, Gomez-Lechon MJ, David M, et al. (1990) Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12, 1179–1186.
36Correa P, Piazuelo MB & Camargo MC (2004) The future of gastric cancer prevention. Gastric Cancer 7, 9–16.
37Correa P, Fontham ET, Bravo JC, et al. (2000) Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92, 1881–1888.
38Qiao YL, Dawsey SM, Kamangar F, et al. (2009) Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 101, 507–518.
39Hercberg S, Kesse-Guyot E, Druesne-Pecollo N, et al. (2010) Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study. Int J Cancer 127, 1875–1881.
40Mandl J, Szarka A & Banhegyi G (2009) Vitamin C: update on physiology and pharmacology. Br J Pharmacol 157, 1097–1110.